Skip to content

RDNT

RadNet, Inc.

NASDAQ · Healthcare · Medical - Diagnostics & Research · US

$73.71
−1.22%
Ask drillr

Income statement

MetricTTM2025202420232022
Revenue
Total Revenue2.3B2.0B1.8B1.6B1.4B
Cost of Revenue2.0B1.9B1.6B1.4B1.3B
Gross Profit220.1M90.8M249.1M221.4M165.7M
Operating Expenses
R&D Expense
SG&A Expense
General & Admin Expense
Selling & Marketing Expense
Other Expenses129.3M144.5M122.7M119.4M
Total Operating Expenses129.3M144.5M122.7M119.4M
Cost and Expenses2.2B1.9B1.7B1.5B1.4B
Operating Income (EBIT)90.8M90.8M104.6M98.7M46.4M
Non-Operating
Interest Income5.1M
Interest Expense71.3M69.9M79.8M64.5M50.8M
Net Interest Income(66.2M)(69.9M)(79.8M)(64.5M)(50.8M)
Other Non-Op Income/Expense(55.9M)(58.9M)(59.8M)(59.9M)(3.4M)
Non-Operating Income (excl Interest)(15.4M)(11.0M)(20.1M)(4.6M)(47.4M)
EBT (Pre-Tax Income)35.0M31.9M44.9M38.8M43.0M
Income Tax Expense15.7M14.9M6.0M8.5M9.4M
Bottom Line
Net Income(21.1M)(18.7M)2.8M3.0M10.7M
Earnings from Cont. Ops19.3M17.0M38.8M30.3M33.6M
Earnings from Discont. Ops
Bottom Line Net Income(21.1M)(18.7M)2.8M3.0M10.7M
Per Share
Basic EPS($0.27)($0.25)$0.04$0.05$0.19
Diluted EPS($0.27)($0.25)$0.04$0.05$0.17
Revenue Per Share$29.17$27.13$25.05$25.43$25.40
Shares
Basic Shares Outstanding77.8M75.2M73.0M63.6M56.3M
Diluted Shares Outstanding78.7M75.2M74.8M64.7M57.3M
Profitability Metrics
EBITDA337.3M253.9M262.5M292.8M278.5M
D&A231.0M152.1M137.8M189.5M184.7M
EBIT106.3M101.8M124.7M103.3M93.8M

As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Jun 1, 2026